MARE DNAseq for Newborn Screening

About Biostate AI

Biostate AI is a global, integrated biotechnology company building a full-stack platform for precision health, spanning from proprietary wet lab sequencing technologies to autonomous AI scientific research. The company has established a significant international footprint through subsidiaries and joint ventures in the US, China, India, and Saudi Arabia, focusing on generating high-fidelity genomic data at reduced cost and translating it into actionable clinical insights. Led by a team with strong academic and commercial backgrounds, including a CEO with a track record of venture fundraising and revenue generation, Biostate appears to be in an early-revenue stage, leveraging its platform for both internal programs and external collaborations. Its strategy hinges on scaling data generation and applying AI to enable proactive, predictive healthcare.